⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001360463

Dillaha Larry

Reports to the SEC for 3 companies · CHANDLER, AZ

Transactions

18

Companies

3

Filings

3

CIK

0001360463

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-03-05	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−112K sh	—	—	0
2014-03-05	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+18.8K sh	$10.89	+$204K	21,875
2014-03-05	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+19.1K sh	$3.54	+$67.5K	40,931
2014-03-05	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+112K sh	$1.83	+$205K	153,057
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−97.8K sh	$72.65	−$7.1M	55,268
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−537 sh	$84.72	−$45.5K	54,731
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−653 sh	$83.92	−$54.8K	54,078
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−624 sh	$82.55	−$51.5K	53,454
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,680 sh	$81.91	−$383K	48,774
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,717 sh	$80.25	−$459K	43,057
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,811 sh	$79.81	−$304K	39,246
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,304 sh	$78.59	−$181K	36,942
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−17.9K sh	$77.24	−$1.38M	19,079
2014-03-05	Insys Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−16K sh	$76.25	−$1.22M	3,125
2014-03-05	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−18.8K sh	—	—	81,250
2014-03-05	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−19.1K sh	—	—	29,944
2013-05-14	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2007-08-09	SCIELE PHARMA, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−875 sh	$23.50	−$20.6K	51,112

Recent filings

3

Accepted (ET)
Mar 64
Insys Therapeutics, Inc.0001209191-14-018066
SEC(opens sec.gov)
May 164
Dillaha Larry0001209191-13-026773
SEC(opens sec.gov)
Aug 134
SCIELE PHARMA, INC.0001104659-07-061870
SEC(opens sec.gov)

Companies

3

Address

444 SOUTH ELLIS STREET

CHANDLER, AZ, 85224